Biogen (BIIB) Long-Term Debt Repayments (2021 - 2025)

Biogen has reported Long-Term Debt Repayments for 5 years, with the latest figure at $1.8 billion in Q2 2025.

• On a quarterly basis, Long-Term Debt Repayments rose 600.0% year-over-year to $1.8 billion in Q2 2025; TTM through Dec 2025 was $1.8 billion, a 169.23% increase from a year earlier, with the FY2025 full-year figure at $1.8 billion, up 169.23% from the prior year.
• Long-Term Debt Repayments was $1.8 billion for Q2 2025 at Biogen, up from $250.0 million in the prior quarter.
• The five-year high for Long-Term Debt Repayments was $1.8 billion in Q2 2025, with the low at $700000.0 in Q2 2021.
• Average Long-Term Debt Repayments over 5 years is $547.8 million, with a median of $325.0 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2025: Long-Term Debt Repayments tumbled 84.05% in 2023, then soared 600.0% in 2025.
• Over 5 years, Long-Term Debt Repayments stood at $700000.0 in 2021, then soared by 143071.43% to $1.0 billion in 2022, then slumped by 35.14% to $650.0 million in 2023, then slumped by 61.54% to $250.0 million in 2024, then jumped by 600.0% to $1.8 billion in 2025.
• The last three Long-Term Debt Repayments figures came in at $1.8 billion (Q2 2025), $250.0 million (Q2 2024), and $400.0 million (Q1 2024), per Business Quant data.